tirzepatide news today is a New Medication for Diabetes and Weight Loss F.D.A. Approves New Obesity Drug
Description
& Cavanagh, J
Tapering is not the right approach for everyone, and the plan should always be guided by a prescribing clinician
Immediately discontinue QSYMIA if symptoms develop
Clin Ther 2016;38(10):21352141
Longer-term studies show patients typically lose 1-2 pounds per week over months 2-6 with consistent semaglutide therapy
